Write in a clean editor, then format for Transplantation Reports in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Transplantation Reports is a peer-reviewed journal published by Elsevier, covering Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes, Organ Donation and Transplantation.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Transplantation Reports 12 (2023) 45–58.
Formats any DOI in Transplantation Reports style. No sign-up. |
| Publishes research in | Renal Transplantation Outcomes and Treatments Organ Transplantation Techniques and Outcomes Organ Donation and Transplantation Transplantation: Methods and Outcomes Liver Disease and Transplantation |
| ISSN | 2451-9596 |
| Citation impact (2-yr) | 0.55 |
| h-index | 7 |
| i10-index | 3 |
| Total citations | 347 |
| Article processing charge | $1,800 |
| Open access | Yes |
| Top institutions publishing here | University of California, Los Angeles |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Sirolimus, is used in ~5% of all US transplant centers as part of a maintenance immunosuppression regimen following solid organ transplantation. In previous published results, we showed that the use of a Sirolimus-based, early steroid withdrawal immunosuppression regimen improved patient and graft 10-year survival. In this study, we aimed to determine whether long-term Sirolimus use…
Objective: To examine current immunosuppressive regimens administered to kidney transplant recipients (KTRs) in South-eastern Europe. Methods: This was a 12-month, multicenter, non-interventional, prospective, observational study of immunosuppressive regimens in adult de novo and maintenance KTRs. The primary endpoint was to identify the number, type, dosage and trough concentrations (C0) of immunosuppressive medications. Results: Data were…
Graft-versus-host disease (GVHD) continues to emerge as the topmost causative factor of the morbidity and mortality rate post hematopoietic stem cell transplantation. The graft cells attack the recipient host tissues resulting in acute or chronic GVHD that affect organs, including the lung, liver, skin, and gastrointestinal tract. Certain factors are considered to play a crucial…
Chronic rejection of transplanted organs remains an unresolved issue in clinical organ transplantation. The macrophages play a crucial role in the development of chronic rejection. We showed previously that macrophage-specific deletion of RhoA or RhoA/ROCK inhibition prevent macrophage movement to the cardiac allografts and abrogate chronic rejection in rodent transplantation models. Here we assessed the…
The introduction of assays for donor-derived cell-free DNA into clinical transplant medicine has provided an additional method to assess allograft health. We compared the performance of two of these assays, Prospera™ and AlloSure®. A series of 15 paired-samples from individual kidney transplant recipients were tested using both Prospera™ and AlloSure® assays simultaneously. Test performances were…
